-
1
-
-
84897461671
-
Development of pharmacological strategies for mitochondrial disorders
-
Kanabus M, Heales SJ, Rahman S. Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol 2014;171:1798-817.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 1798-1817
-
-
Kanabus, M.1
Heales, S.J.2
Rahman, S.3
-
2
-
-
0019423856
-
Sequence and organization of the human mitochondrial genome
-
Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-65.
-
(1981)
Nature
, vol.290
, pp. 457-465
-
-
Anderson, S.1
Bankier, A.T.2
Barrell, B.G.3
-
3
-
-
84928157053
-
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
-
Gorman GS, Schaefer AM, Ng Y, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015;77:753-9.
-
(2015)
Ann Neurol
, vol.77
, pp. 753-759
-
-
Gorman, G.S.1
Schaefer, A.M.2
Ng, Y.3
-
6
-
-
0035851099
-
The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes
-
Schagger H, Pfeiffer K. The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J Biol Chem 2001;276:37861-7.
-
(2001)
J Biol Chem
, vol.276
, pp. 37861-37867
-
-
Schagger, H.1
Pfeiffer, K.2
-
7
-
-
84863874490
-
Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
-
Horvath R. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10). J Inherit Metab Dis 2012;35:679-87.
-
(2012)
J Inherit Metab Dis
, vol.35
, pp. 679-687
-
-
Horvath, R.1
-
8
-
-
78149325680
-
A randomized trial of coenzyme Q10 in mitochondrial disorders
-
Glover EI, Martin J, Maher A, et al. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 2010;42:739-48.
-
(2010)
Muscle Nerve
, vol.42
, pp. 739-748
-
-
Glover, E.I.1
Martin, J.2
Maher, A.3
-
9
-
-
70350136445
-
A modern approach to the treatment of mitochondrial disease
-
Parikh S, Saneto R, Falk MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414-30.
-
(2009)
Curr Treat Options Neurol
, vol.11
, pp. 414-430
-
-
Parikh, S.1
Saneto, R.2
Falk, M.J.3
-
11
-
-
77955283395
-
Animal and human studies with the mitochondria-targeted antioxidant MitoQ
-
Smith RAJ, Murphy MP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010;1201:96-103.
-
(2010)
Ann N y Acad Sci
, vol.1201
, pp. 96-103
-
-
Smith, R.A.J.1
Murphy, M.P.2
-
12
-
-
0021744023
-
Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition
-
Suno M, Nagaoka A. Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of the inhibition. Biochem Biophys Res Commun 1984;125:1046-52.
-
(1984)
Biochem Biophys Res Commun
, vol.125
, pp. 1046-1052
-
-
Suno, M.1
Nagaoka, A.2
-
14
-
-
84874322602
-
Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy
-
Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy. Brain 2013;136(Pt 2):e230.
-
(2013)
Brain
, vol.136
, pp. e230
-
-
Klopstock, T.1
Metz, G.2
Yu-Wai-Man, P.3
-
15
-
-
80052958201
-
Idebenone treatment in Leber's hereditary optic neuropathy
-
Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber's hereditary optic neuropathy. Brain 2011;134(Pt 9):e188.
-
(2011)
Brain
, vol.134
, pp. e188
-
-
Carelli, V.1
La Morgia, C.2
Valentino, M.L.3
-
16
-
-
0035074293
-
Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency
-
Binzak BA, Wevers RA, Moolenaar SH, et al. Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. Am J Hum Genet 2001;68:839-47.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 839-847
-
-
Binzak, B.A.1
Wevers, R.A.2
Moolenaar, S.H.3
-
17
-
-
0037241026
-
The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial
-
Liet J-M, Pelletier V, Robinson BH, et al. The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial. J Pediatr 2003;142: 62-6.
-
(2003)
J Pediatr
, vol.142
, pp. 62-66
-
-
Liet, J.-M.1
Pelletier, V.2
Robinson, B.H.3
-
19
-
-
0242497007
-
Carnitine palmitoyltransferase II deficiency: A clinical, biochemical, and molecular review
-
Sigauke E, Rakheja D, Kitson K, et al. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review. Lab Investig 2003;83:1543-54.
-
(2003)
Lab Investig
, vol.83
, pp. 1543-1554
-
-
Sigauke, E.1
Rakheja, D.2
Kitson, K.3
-
20
-
-
20844443983
-
L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial
-
Schöls L, Zange J, Abele M, et al. L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm 2005;112:789-96.
-
(2005)
J Neural Transm
, vol.112
, pp. 789-796
-
-
Schöls, L.1
Zange, J.2
Abele, M.3
-
21
-
-
71549160839
-
Carnitine, mitochondrial function and therapy
-
Zammit VA, Ramsay RR, Bonomini M, et al. Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev 2009;61:1353-62.
-
(2009)
Adv Drug Deliv Rev
, vol.61
, pp. 1353-1362
-
-
Zammit, V.A.1
Ramsay, R.R.2
Bonomini, M.3
-
22
-
-
34547683384
-
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol
-
Kato M, Li J, Chuang JL, et al. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Structure 2007;15:992-1004.
-
(2007)
Structure
, vol.15
, pp. 992-1004
-
-
Kato, M.1
Li, J.2
Chuang, J.L.3
-
23
-
-
84878480298
-
Long-term safety of dichloroacetate in congenital lactic acidosis
-
Abdelmalak M, Lew A, Ramezani R, et al. Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab 2013;109:139-43.
-
(2013)
Mol Genet Metab
, vol.109
, pp. 139-143
-
-
Abdelmalak, M.1
Lew, A.2
Ramezani, R.3
-
24
-
-
33646202306
-
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
-
Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006;66:324-30.
-
(2006)
Neurology
, vol.66
, pp. 324-330
-
-
Kaufmann, P.1
Engelstad, K.2
Wei, Y.3
-
25
-
-
84890567997
-
Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease
-
Mercer JR. Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease. Pharmacol Ther 2014;141:13-20.
-
(2014)
Pharmacol Ther
, vol.141
, pp. 13-20
-
-
Mercer, J.R.1
-
26
-
-
84855355930
-
Initial experience in the treatment of inherited mitochondrial disease with EPI-743
-
Enns GM, Kinsman SL, Perlman SL, et al. Initial experience in the treatment of inherited mitochondrial disease with EPI-743. Mol Genet Metab 2012;105: 91-102.
-
(2012)
Mol Genet Metab
, vol.105
, pp. 91-102
-
-
Enns, G.M.1
Kinsman, S.L.2
Perlman, S.L.3
-
27
-
-
84876167339
-
Review of clinical trials for mitochondrial disorders: 1997-2012
-
Kerr DS. Review of clinical trials for mitochondrial disorders: 1997-2012. Neurotherapeutics 2013;10:307-19.
-
(2013)
Neurotherapeutics
, vol.10
, pp. 307-319
-
-
Kerr, D.S.1
-
28
-
-
77954455562
-
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation
-
Mancuso M, Orsucci D, Logerfo A, et al. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol 2010; 257:774-81.
-
(2010)
J Neurol
, vol.257
, pp. 774-781
-
-
Mancuso, M.1
Orsucci, D.2
Logerfo, A.3
-
29
-
-
0031596641
-
Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria
-
Zimmer G, Balakirev M, Zwicker K, et al. Effect of the triaminopyridine flupirtine on calcium uptake, membrane potential and ATP synthesis in rat heart mitochondria. Br J Pharmacol 1998;123:1154-8.
-
(1998)
Br J Pharmacol
, vol.123
, pp. 1154-1158
-
-
Zimmer, G.1
Balakirev, M.2
Zwicker, K.3
-
30
-
-
0031792788
-
Antioxidant properties of the triaminopyridine, flupirtine
-
Gassen M, Pergande G, Youdim MB. Antioxidant properties of the triaminopyridine, flupirtine. Biochem Pharmacol 1998;56:1323-9.
-
(1998)
Biochem Pharmacol
, vol.56
, pp. 1323-1329
-
-
Gassen, M.1
Pergande, G.2
Youdim, M.B.3
-
31
-
-
0034623311
-
Protection of mitochondrial integrity from oxidative stress by the triaminopyridine derivative flupirtine
-
Schlüter T, Struy H, Schönfeld P. Protection of mitochondrial integrity from oxidative stress by the triaminopyridine derivative flupirtine. FEBS Lett 2000;481:42-6.
-
(2000)
FEBS Lett
, vol.481
, pp. 42-46
-
-
Schlüter, T.1
Struy, H.2
Schönfeld, P.3
-
32
-
-
76049085255
-
Freeradical scavenging and mitochondrial antioxidant activities of reishi-ganoderma lucidum (Curt: Fr) P. Karst and arogyapacha-trichopus zeylanicus gaertn extracts
-
Cherian E, Sudheesh NP, Janardhanan KK, et al. Freeradical scavenging and mitochondrial antioxidant activities of Reishi-Ganoderma lucidum (Curt: Fr) P. Karst and Arogyapacha-Trichopus zeylanicus Gaertn extracts. J Basic Clin Physiol Pharmacol 2009;20:289-307.
-
(2009)
J Basic Clin Physiol Pharmacol
, vol.20
, pp. 289-307
-
-
Cherian, E.1
Sudheesh, N.P.2
Janardhanan, K.K.3
-
33
-
-
62549137824
-
Transcriptome analysis of cadmium response in ganoderma lucidum
-
Chuang HW, Wang IW, Lin SY, et al. Transcriptome analysis of cadmium response in Ganoderma lucidum. FEMS Microbiol Lett 2009;293:205-13.
-
(2009)
FEMS Microbiol Lett
, vol.293
, pp. 205-213
-
-
Chuang, H.W.1
Wang, I.W.2
Lin, S.Y.3
-
34
-
-
59649122561
-
Effect of ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats
-
Ajith TA, Sudheesh NP, Roshny D, et al. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. Exp Gerontol 2009;44:219-23.
-
(2009)
Exp Gerontol
, vol.44
, pp. 219-223
-
-
Ajith, T.A.1
Sudheesh, N.P.2
Roshny, D.3
-
35
-
-
84863620242
-
Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease
-
Chen L-W, Horng L-Y, Wu C-L, et al. Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. Neuropharmacology 2012;63:719-32.
-
(2012)
Neuropharmacology
, vol.63
, pp. 719-732
-
-
Chen, L.-W.1
Horng, L.-Y.2
Wu, C.-L.3
-
36
-
-
84897457350
-
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
-
Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 2014;171:2029-50.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 2029-2050
-
-
Szeto, H.H.1
-
37
-
-
84897388046
-
Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis
-
Birk AV, Chao WM, Bracken C, et al. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 2014;171:2017-28.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 2017-2028
-
-
Birk, A.V.1
Chao, W.M.2
Bracken, C.3
-
38
-
-
33751011308
-
PGC-1alpha: A key regulator of energy metabolism
-
Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 2006;30:145-51.
-
(2006)
Adv Physiol Educ
, vol.30
, pp. 145-151
-
-
Liang, H.1
Ward, W.F.2
-
39
-
-
84882827626
-
Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy
-
Noe N, Dillon L, Lellek V, et al. Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion 2013;13:417-26.
-
(2013)
Mitochondrion
, vol.13
, pp. 417-426
-
-
Noe, N.1
Dillon, L.2
Lellek, V.3
-
40
-
-
84856092782
-
Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
-
Yatsuga S, Suomalainen A. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21:526-35.
-
(2012)
Hum Mol Genet
, vol.21
, pp. 526-535
-
-
Yatsuga, S.1
Suomalainen, A.2
-
41
-
-
84897418338
-
Turn up the power-pharmacological activation of mitochondrial biogenesis in mouse models
-
Komen JC, Thorburn DR. Turn up the power-pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 2014;171:1818-36.
-
(2014)
Br J Pharmacol
, vol.171
, pp. 1818-1836
-
-
Komen, J.C.1
Thorburn, D.R.2
-
42
-
-
77953808955
-
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency
-
Bonnefont JP, Bastin J, Laforêt P, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther 2010;88:101-8.
-
(2010)
Clin Pharmacol Ther
, vol.88
, pp. 101-108
-
-
Bonnefont, J.P.1
Bastin, J.2
Laforêt, P.3
-
43
-
-
84871118476
-
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man
-
Hoffmann E, Wald J, Lavu S, et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol 2013;75:186-96.
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 186-196
-
-
Hoffmann, E.1
Wald, J.2
Lavu, S.3
-
44
-
-
84871431259
-
A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers
-
Libri V, Brown AP, Gambarota G, et al. A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS ONE 2012;7:e51395.
-
(2012)
PLoS ONE
, vol.7
, pp. e51395
-
-
Libri, V.1
Brown, A.P.2
Gambarota, G.3
-
45
-
-
84897493440
-
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
-
Groenewoud MJ, Zwartkruis FJT. Rheb and mammalian target of rapamycin in mitochondrial homoeostasis. Open Biol 2013;3:130185.
-
(2013)
Open Biol
, vol.3
, pp. 130185
-
-
Groenewoud, M.J.1
Zwartkruis, F.J.T.2
-
46
-
-
36749081539
-
MTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex
-
Cunningham JT, Rodgers JT, Arlow DH, et al. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 2007;450: 736-40.
-
(2007)
Nature
, vol.450
, pp. 736-740
-
-
Cunningham, J.T.1
Rodgers, J.T.2
Arlow, D.H.3
-
47
-
-
84890850876
-
MTOR inhibition alleviates mitochondrial disease in a mouse model of leigh syndrome
-
Johnson SC, Yanos ME, Kayser E-B, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 2013;342:1524-8.
-
(2013)
Science
, vol.342
, pp. 1524-1528
-
-
Johnson, S.C.1
Yanos, M.E.2
Kayser, E.-B.3
-
49
-
-
80055050942
-
Screening for active small molecules in mitochondrial complex I deficient Patient's fibroblasts, reveals AICAR as the most beneficial compound
-
Golubitzky A, Dan P, Weissman S, et al. Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PLoS ONE 2011;6:e26883.
-
(2011)
PLoS ONE
, vol.6
, pp. e26883
-
-
Golubitzky, A.1
Dan, P.2
Weissman, S.3
-
51
-
-
69949092670
-
Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications
-
Chen J-Q, Cammarata PR, Baines CP, et al. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009;1793:1540-70.
-
(2009)
Biochim Biophys Acta
, vol.1793
, pp. 1540-1570
-
-
Chen, J.-Q.1
Cammarata, P.R.2
Baines, C.P.3
-
52
-
-
79954490671
-
Genistein and folic acid prevent oxidative injury induced by β-amyloid peptide
-
Ding B, Yuan L, Yu H, et al. Genistein and folic acid prevent oxidative injury induced by β-amyloid peptide. Basic Clin Pharmacol Toxicol 2011;108:333-40.
-
(2011)
Basic Clin Pharmacol Toxicol
, vol.108
, pp. 333-340
-
-
Ding, B.1
Yuan, L.2
Yu, H.3
-
53
-
-
71849091967
-
Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
-
Beal MF. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 3):S189-94.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, pp. S189-S194
-
-
Beal, M.F.1
-
54
-
-
84925503952
-
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
-
Sajish M, Schimmel P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature 2014;519:370-3.
-
(2014)
Nature
, vol.519
, pp. 370-373
-
-
Sajish, M.1
Schimmel, P.2
-
55
-
-
79957959973
-
Neuroprotective effect of nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
-
Neymotin A, Calingasan NY, Wille E, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 2011;51:88-96.
-
(2011)
Free Radic Biol Med
, vol.51
, pp. 88-96
-
-
Neymotin, A.1
Calingasan, N.Y.2
Wille, E.3
-
56
-
-
84962030356
-
Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans
-
Van de Weijer T, Phielix E, Bilet L, et al. Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 2015;64:1193-201.
-
(2015)
Diabetes
, vol.64
, pp. 1193-1201
-
-
Van De-Weijer, T.1
Phielix, E.2
Bilet, L.3
-
57
-
-
34247271282
-
SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress
-
Scher MB, Vaquero A, Reinberg D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 2007;21:920-8.
-
(2007)
Genes Dev
, vol.21
, pp. 920-928
-
-
Scher, M.B.1
Vaquero, A.2
Reinberg, D.3
-
58
-
-
84880517634
-
The NAD+/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling
-
Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD+/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013;154:430-41.
-
(2013)
Cell
, vol.154
, pp. 430-441
-
-
Mouchiroud, L.1
Houtkooper, R.H.2
Moullan, N.3
-
59
-
-
84901848955
-
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
-
Khan NA, Auranen M, Paetau I, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014;6:721-31.
-
(2014)
EMBO Mol Med
, vol.6
, pp. 721-731
-
-
Khan, N.A.1
Auranen, M.2
Paetau, I.3
-
60
-
-
84902245774
-
NAD(+)-dependent activation of sirt1 corrects the phenotype in a mouse model of mitochondrial disease
-
Cerutti R, Pirinen E, Lamperti C, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014;19:1042-9.
-
(2014)
Cell Metab
, vol.19
, pp. 1042-1049
-
-
Cerutti, R.1
Pirinen, E.2
Lamperti, C.3
-
61
-
-
84862022077
-
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
-
Cantó C, Houtkooper RH, Pirinen E, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 2012;15:838-47.
-
(2012)
Cell Metab
, vol.15
, pp. 838-847
-
-
Cantó, C.1
Houtkooper, R.H.2
Pirinen, E.3
-
63
-
-
84859429137
-
Molecular pathology of MELAS and L-arginine effects
-
Koga Y, Povalko N, Nishioka J, et al. Molecular pathology of MELAS and L-arginine effects. Biochim Biophys Acta 2012;1820:608-14.
-
(2012)
Biochim Biophys Acta
, vol.1820
, pp. 608-614
-
-
Koga, Y.1
Povalko, N.2
Nishioka, J.3
-
64
-
-
84893049149
-
Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome
-
El-Hattab AW, Emrick LT, Chanprasert S, et al. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome. Int J Biochem Cell Biol 2014;48:85-91.
-
(2014)
Int J Biochem Cell Biol
, vol.48
, pp. 85-91
-
-
El-Hattab, A.W.1
Emrick, L.T.2
Chanprasert, S.3
-
65
-
-
84867895466
-
Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders
-
El-Hattab AW, Emrick LT, Craigen WJ, et al. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol Genet Metab 2012;107:247-52.
-
(2012)
Mol Genet Metab
, vol.107
, pp. 247-252
-
-
El-Hattab, A.W.1
Emrick, L.T.2
Craigen, W.J.3
-
66
-
-
78649711229
-
Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography
-
Arakawa K, Kudo T, Ikawa M, et al. Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography. Circ J 2010;74:2702-11.
-
(2010)
Circ J
, vol.74
, pp. 2702-2711
-
-
Arakawa, K.1
Kudo, T.2
Ikawa, M.3
-
67
-
-
84930638309
-
L-arginine affects aerobic capacity and muscle metabolism in MELAS (Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes) syndrome
-
Rodan LH, Wells GD, Banks L, et al. L-Arginine affects aerobic capacity and muscle metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) syndrome. PLoS ONE 2015;10:e0127066.
-
(2015)
PLoS ONE
, vol.10
, pp. e0127066
-
-
Rodan, L.H.1
Wells, G.D.2
Banks, L.3
-
68
-
-
84879689589
-
Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins
-
Moreno-Ulloa A, Cid A, Rubio-Gayosso I, et al. Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. Bioorg Med Chem Lett 2013;23:4441-6.
-
(2013)
Bioorg Med Chem Lett
, vol.23
, pp. 4441-4446
-
-
Moreno-Ulloa, A.1
Cid, A.2
Rubio-Gayosso, I.3
-
69
-
-
80052793189
-
Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle
-
Nogueira L, Ramirez-Sanchez I, Perkins GA, et al. (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J Physiol 2011;589(Pt 18): 4615-31.
-
(2011)
J Physiol
, vol.589
, pp. 4615-4631
-
-
Nogueira, L.1
Ramirez-Sanchez, I.2
Perkins, G.A.3
-
70
-
-
84867763101
-
Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease
-
Garrido-Maraver J, Cordero MD, Moñino ID, et al. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease. Br J Pharmacol 2012;167:1311-28.
-
(2012)
Br J Pharmacol
, vol.167
, pp. 1311-1328
-
-
Garrido-Maraver, J.1
Cordero, M.D.2
Moñino, I.D.3
|